Clinical Trials Directory

Trials / Unknown

UnknownNCT01910584

Quality of Life and Sexual Function of the Novasure Endometrial Ablation in Menorrhagia

Prospective Study of the Influence on Quality of Life and Sexual Function of the Novasure Endometrial Ablation in the Treatment of Menorrhagia

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Shu-Qin Chen · Academic / Other
Sex
Female
Age
25 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the influence on the quality of life and sexual function before, 6 month and one year after Novasure Endometrial Ablation in the treatment of Menorrhagia.

Detailed description

patients diagnosed menorrhagia scheduled for Novasure Endometrial Ablation because of menorrhagia between november, 2012 and november, 2014 are enrolled to this study. patients are asked to complete preoperative questionnaires considering Health Related Quality of Life questionnaire(HRQoL) and sexual Female Sexual Functioning Index questionnaire(FSFI). Same questionnaires will also be completed six months and one year after operation.

Conditions

Interventions

TypeNameDescription
PROCEDURENovasure endometrial ablationNovasure endometrial ablation is the second generation endometrial ablation treatment aimed to cure the dysfunctional uterine bleeding(DUB),including menorrhagia.

Timeline

Start date
2012-11-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2013-07-29
Last updated
2013-07-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01910584. Inclusion in this directory is not an endorsement.